How Does Utovlan Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Utovlan (Norethisterone) Works
- Primary Action: Synthetic progestogen that mimics natural progesterone
- Receptor Binding: Binds to progesterone receptors in uterus, pituitary, and other tissues
- Endometrial Effect: Stabilises the womb lining, reducing heavy or irregular bleeding
- Hormonal Feedback: Suppresses LH and FSH to delay ovulation and periods
- Onset of Action: Effects begin within hours; peak plasma levels at 1-2 hours
- Duration: Half-life 8-10 hours; most eliminated within 24-48 hours
Utovlan (norethisterone) works by acting like the natural hormone progesterone in your body. It helps regulate the menstrual cycle, treat heavy or painful periods, and can delay your period when needed. Below we explain exactly how it works at the chemical and cellular level.
Important Medical Advice
If you experience symptoms of a blood clot (sudden chest pain, difficulty breathing, calf swelling), severe allergic reaction (swelling of face, difficulty breathing), or jaundice (yellowing skin/eyes) while taking Utovlan, seek immediate medical attention. Do not take Utovlan if you are pregnant or have a history of blood clots.
Chemical Composition & Molecular Structure of Utovlan
Utovlan contains the active ingredient norethisterone, a synthetic progestogen derived from 19-nortestosterone. Its chemical structure allows it to bind strongly to progesterone receptors.
Chemical Structure Details
17α-ethinyl-17-hydroxy-19-nor-4-androsten-3-one
Also known as 19-norethisterone. The ethinyl group at position 17 makes it orally active.
C20H26O2
20 carbon, 26 hydrogen, and 2 oxygen atoms.
298.42 g/mol
As the free base; in tablets it is present as norethisterone.
Key Pharmaceutical Properties
| Property | Value/Characteristic | Clinical Significance |
|---|---|---|
| Solubility | Practically insoluble in water, soluble in alcohol | Formulated with lactose and starch for absorption |
| Bioavailability | Approx. 64% (oral) | Good oral absorption due to ethinyl group |
| Protein Binding | 97% bound to albumin and SHBG | High binding affects free drug concentration |
| Receptor Affinity | High for progesterone receptors; weak for androgen receptors | Progestogenic effects dominant; mild androgenic possible |
🗒️ Pharmaceutical Insight: The 17α-ethinyl group prevents rapid first-pass metabolism, making norethisterone effective orally. This structural modification distinguishes it from natural progesterone.
Mechanism of Action: How Utovlan Creates Its Effects
Norethisterone works primarily by binding to progesterone receptors, triggering a cascade of effects that mimic the natural hormone progesterone.
Key Actions in the Body
- Uterine Effects: Converts the proliferative endometrium to a secretory state, stabilising the lining and reducing breakthrough bleeding.
- Pituitary Feedback: Suppresses gonadotropin (LH and FSH) release, inhibiting ovulation when taken continuously.
- Cervical Mucus: Thickens cervical mucus, making it harder for sperm to penetrate (minor contribution).
- Endometriosis: Causes atrophy of ectopic endometrial tissue by creating a hypoestrogenic state.
- Period Delay: Maintains the endometrium, postponing menstrual shedding until after treatment stops.
Comparison with Natural Progesterone
| Feature | Natural Progesterone | Norethisterone (Utovlan) |
|---|---|---|
| Oral activity | Poor (low bioavailability) | Good due to 17α-ethinyl group |
| Receptor selectivity | Selective for progesterone receptors | Also binds weakly to androgen receptors |
| Half-life | ~5 minutes | 8-10 hours |
| Endometrial effect | Secretory transformation | Secretory transformation + stabilisation |
🗒️ Physiological Insight: Utovlan does not work immediately to stop bleeding – it needs time to build up the endometrial lining. For period delay, start 3 days before expected period.
Receptor Binding & Selectivity of Utovlan
Norethisterone exerts its effects by binding to intracellular progesterone receptors (PR) with high affinity. It also has weak interactions with other steroid receptors.
Binding Characteristics
High affinity (Kd ~0.1 nM)
Full agonist activity, triggering gene transcription and protein synthesis.
Low affinity (approx. 5% of testosterone)
May cause mild androgenic effects like acne or hirsutism at high doses.
No binding
No estrogenic activity; can oppose estrogen effects.
Tissue Distribution of Progesterone Receptors
| Tissue | Receptor Presence | Effect of Norethisterone |
|---|---|---|
| Uterus (endometrium) | High | Secretory transformation, stabilisation |
| Pituitary gland | Moderate | Suppression of LH and FSH |
| Breast tissue | Moderate | Lobular development; possible tenderness |
| Hypothalamus | Low | Negative feedback on GnRH |
🗒️ Pharmacology Insight: The weak androgenic activity of norethisterone is dose-dependent. At standard therapeutic doses (5-15 mg/day), androgenic effects are minimal, but high-dose breast cancer treatment (40-60 mg/day) may cause them.
Metabolic Effects & Duration in the Body
Norethisterone is metabolised primarily in the liver and has a half-life that determines dosing frequency.
Metabolic Pathway
Phase I Metabolism
Location: Liver (CYP3A4 and other enzymes)
Process: Reduction of A-ring and hydroxylation
Result: Multiple metabolites, some active (e.g., 5α-dihydronorethisterone)
Phase II Metabolism
Process: Conjugation with glucuronide and sulfate
Result: Water-soluble metabolites for excretion
Elimination
Route: 70% urine, 30% feces
Half-life: 8-10 hours (parent drug)
Active Metabolites: Some have weak progestogenic activity
Timeline of Effects After a Single 5mg Dose
- 0-2 hours: Absorption; peak plasma concentration reached.
- 2-6 hours: Maximum receptor binding and biological effect.
- 6-12 hours: Gradual decline; progestogenic effect maintained.
- 12-24 hours: Most drug eliminated; repeated dosing needed for continuous effect.
- 24-48 hours: No significant drug remaining; withdrawal bleed occurs 2-4 days after stopping.
🗒️ Clinical Correlation: Because of the 8-10 hour half-life, Utovlan is usually taken 2-3 times daily for conditions like heavy bleeding or endometriosis to maintain stable levels. For period delay, three times daily is standard.
Absorption, Distribution & Elimination
Understanding how Utovlan moves through the body helps explain its onset and duration.
Pharmacokinetic Profile
Absorption
Bioavailability: ~64% (oral)
Peak Time: 1-2 hours
Food Effect: No significant delay; can be taken with or without food
Distribution
Volume: 4-5 L/kg (extensive tissue binding)
Protein Binding: 97% (albumin, SHBG)
Tissue Penetration: Good in reproductive organs
Elimination
Half-life: 8-10 hours
Renal Excretion: 70% as metabolites
Fecal Excretion: 30%
Special Population Considerations
| Population | Effect on Norethisterone | Dosing Consideration |
|---|---|---|
| Hepatic impairment | Reduced metabolism, increased levels | Contraindicated in severe liver disease |
| Renal impairment | Minimal effect (renal excretion of metabolites) | No dose adjustment usually needed |
| Drug interactions (CYP3A4 inducers) | Reduced efficacy (e.g., rifampicin, St John's wort) | Consider alternative or increased dose |
🗒️ Clinical Warning: Drugs that induce liver enzymes (like some epilepsy medicines) can lower norethisterone levels and reduce its effectiveness. Always tell your doctor about all medicines you take.
Clinical Efficacy for Period Problems & Other Uses
Utovlan is proven effective for several menstrual conditions, as supported by clinical studies and the PIL.
Efficacy Data from Clinical Use
| Condition | Typical Dose | Success Rate / Outcome |
|---|---|---|
| Heavy menstrual bleeding | 5mg three times daily for 10 days | Reduces blood loss by 50-80% in most women |
| Endometriosis | 15mg daily for 6+ months | Significant pain relief and lesion atrophy |
| Period delay | 5mg three times daily starting 3 days before period | Effective in >90% for delaying up to 17 days |
| Premenstrual tension | 5mg daily from day 16 to 25 of cycle | Moderate improvement in symptoms |
Optimal Use Guidelines Based on Mechanism
- Timing: For period delay, start 3 days before expected period; for heavy bleeding, start at beginning of cycle or as directed.
- Dose: Follow your doctor's prescription exactly; doses vary by condition.
- Consistency: Take at the same times each day to maintain stable levels.
- Withdrawal bleed: Expect a period 2-4 days after stopping; if no period, check for pregnancy.
- Contraindications: Avoid if history of blood clots, liver disease, or pregnancy.
🗒️ Prescribing Insight: Utovlan is not a contraceptive and does not protect against pregnancy. Use barrier contraception if needed during treatment.
Utovlan Mechanism FAQs
How quickly does Utovlan start working to delay a period?
Utovlan starts working within hours, but to delay a period you need to start taking it 3 days before your expected period. It maintains the womb lining so bleeding doesn't occur until you stop.
Does Utovlan stop ovulation?
At the usual doses for period delay or heavy bleeding, Utovlan may not consistently inhibit ovulation. Continuous high-dose use (e.g., for endometriosis) can suppress ovulation by blocking pituitary hormones.
How is Utovlan different from the contraceptive pill?
Utovlan contains only a progestogen, while most contraceptive pills combine estrogen and progestogen. Utovlan is not licensed for contraception and does not reliably prevent pregnancy.
Can Utovlan cause weight gain?
Some women report weight gain, possibly due to fluid retention or increased appetite. It's listed as a possible side effect, but not everyone experiences it.
Why can't I take Utovlan if I have a history of blood clots?
Progestogens like norethisterone slightly increase the risk of venous thromboembolism. If you've had a clot before, the risk may be too high, so it's contraindicated.
Need Utovlan for Period Delay or Heavy Bleeding?
If you're considering Utovlan to manage your period or delay it for an occasion, speak with a UK-registered doctor through a confidential online consultation.
Secure Prescription & Next-Day Delivery
MHRA-compliant | GPhC-registered pharmacy | Discreet packaging | UK-registered doctors
Start Period Delay ConsultationRelated Utovlan Guides
Clinical References & Sources
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 20 February 2026
Next Review: 20 August 2026
Published on: 20 February 2026
Last Updated: 20 February 2026